 |
|
Unfavorable Effect of Atropine-Diphenoxylate (Lomotil) Therapy in Lincomycin-Caused Diarrhea
Ervin Novak, MD, PhD;
John G. Lee, PhD;
Clarence E. Seckman;
J. Paul Phillips;
Anthony R. DiSanto, PhD
JAMA. 1976;235(14):1451-1454.
Abstract
In this double-blind, randomized study, 200 normal subjects received a three-day course of one of five treatment regimens: lincomycin hydrochloride monohydrate injection (sterile solution, 300 mg/ml) with two tablets of either placebo, a mixture of atropine sulfate and diphenoxylate hydrochloride (Lomotil), an aspirin-phenacetin-caffeine (APC) combination or the latter with codeine, or an injection of saline with two placebo tablets. Gastrointestinal irritation was most prominent in subjects receiving lincomycin with atropine-diphenoxylate and lincomycin with APC plus codeine (P <.05). Decreased intestinal motility from atropine-diphenoxylate or codeine may increase the contact time between the lincomycin (or its metabolites) or some developing toxic substances and the mucosal epithelium. The use of atropine-diphenoxylate or codeine in treating lincomycin-induced diarrhea may be questionable.
(JAMA 235:1451-1454, 1976)
Author Affiliations
From the Upjohn Company, Kalamazoo, Mich.
Footnotes
Reprint requests to the Upjohn Company, 7000 Portage Road, Kalamazoo, MI 49001 (Dr Novak).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Past, Present, and Future Therapies for Clostridium difficile-Associated Disease
Surowiec et al.
The Annals of Pharmacotherapy 2006;40:2155-2163.
ABSTRACT
| FULL TEXT
8. Clindamycin and Lincomycin: Oral and Parenteral Therapy
Veterans Administration Ad Hoc Interdisciplinary A
JAMA 1977;237:1482-1484.
|
